Year Book of Pulmonary Disease 2016

Name: Year Book of Pulmonary Disease 2016 | Year Book of Pulmonary Disease 2016
Brand: Elsevier
Price: 110.99 EUR
Availability: OnlineOnly

Janet R. Maurer Adriel L. Malave Shirin Shafazand Lynn T. Tanoue Sandra K. Willsie(Autor*in)

Elsevier (Verlag)

1. Auflage

Erschienen am 2. August 2016

100 Seiten

E-Book

ePUB mit Adobe-DRM

Systemvoraussetzungen

978-0-323-44695-2 (ISBN)

110,99 €inkl. 7% MwSt.

Systemvoraussetzungen

für ePUB mit Adobe-DRM

E-Book Einzellizenz

Als Download verfügbar

Beschreibung

Weitere Details

Weitere Ausgaben

Inhalt

Cover image
Title page
Table of Contents
1. Asthma, Allergy, and Cystic Fibrosis
1.1 Asthma
Evolving Concepts of Asthma
Abstract
Commentary
Asthma-COPD overlap 2015: now we are six
Abstract
Commentary
Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes
Abstract
Commentary
Treatment of overlapping asthma-chronic obstructive pulmonary disease: Can guidelines contribute in an evidence-free zone?
Abstract
Commentary
Diagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS)
Abstract
Commentary
Effects of Weight Loss on Airway Responsiveness in Obese Adults With Asthma: Does Weight Loss Lead to Reversibility of Asthma?
Abstract
Commentary
Sex difference in the association between obesity and asthma in U.S. adults: Findings from a national study
Abstract
Commentary
Airway Inflammation after Bronchial Thermoplasty for Severe Asthma
Abstract
Commentary
Randomised comparison of intravenous magnesium sulphate, terbutaline and aminophylline for children with acute severe asthma
Abstract
Commentary
Comparative Effectiveness of Dexamethasone versus Prednisone in Children Hospitalized with Asthma
Abstract
Commentary
Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma
Abstract
Commentary
Anticholinergic vs Long-Acting ß-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial
Abstract
Commentary
Once-daily tiotropium Respimat® 5 µg is an efficacious 24-h bronchodilator in adults with symptomatic asthma
Abstract
Commentary
Nebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: A double-blind, double-dummy study
Abstract
Commentary
1.2 Cystic Fibrosis
Update in Cystic Fibrosis 2014
Abstract
Commentary
New and Emerging Treatments for Cystic Fibrosis
Abstract
Commentary
Clinical and demographic factors associated with post-lung transplantation survival in individuals with cystic fibrosis
Abstract
Commentary
Sustained Benefit from Ivacaftor Demonstrated by Combining Clinical Trial and Cystic Fibrosis Patient Registry Data
Abstract
Commentary
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
Abstract
Commentary
Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis
Abstract
Commentary
Pulmonary Hypertension in Cystic Fibrosis with Advanced Lung Disease
Abstract
Commentary
2. Chronic Obstructive Pulmonary Disease
Global and regional trends in COPD mortality, 1990-2010
Abstract
Commentary
Economic Burden of COPD in the Presence of Comorbidities
Abstract
Commentary
Socioeconomic Characteristics Are Major Contributors to Ethnic Differences in Health Status in Obstructive Lung Disease: An Analysis of the National Health and Nutrition Examination Survey 2007-2010
Abstract
Commentary
Determinants of Underdiagnosis of COPD in National and International Surveys
Abstract
Commentary
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
Abstract
Commentary
Palliative needs for heart failure or chronic obstructive pulmonary disease: Results of a multicenter observational registry
Abstract
Commentary
A Mixed Phenotype of Airway Wall Thickening and Emphysema Is Associated with Dyspnea and Hospitalization for Chronic Obstructive Pulmonary Disease
Abstract
Commentary
Asthma, COPD and overlap syndrome: a longitudinal study in young European adults
Abstract
Commentary
Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease
Abstract
Commentary
Discontinuation of Inhaled Corticosteroids in COPD and the Risk Reduction of Pneumonia
Abstract
Commentary
FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease
Abstract
Commentary
Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial
Abstract
Commentary
Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study
Abstract
Commentary
Distractive Auditory Stimuli in the Form of Music in Individuals With COPD: A Systematic Review
Abstract
Commentary
Airway IL-1ß and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD
Abstract
Commentary
Increased Risk of Dementia in Patients With Chronic Obstructive Pulmonary Disease
Abstract
Commentary
Pulmonary Gas Exchange Abnormalities in Mild Chronic Obstructive Pulmonary Disease: Implications for Dyspnea and Exercise Intolerance
Abstract
Commentary
3. Lung Cancer
3.1 Epidemiology of Lung Cancer
Cancer Statistics, 2015
Abstract
Commentary
Airflow Limitation and Histology Shift in the National Lung Screening Trial: The NLST-ACRIN Cohort Substudy
Abstract
Commentary
Asbestos Exposure, Pleural Plaques, and the Risk of Death from Lung Cancer
Abstract
Commentary
3.2 Tobacco-Related Issues
Current Cigarette Smoking Among Adults - United States, 2005-2014
Abstract
Commentary
Randomized Trial of Reduced-Nicotine Standards for Cigarettes
Abstract
Commentary
Financial incentives for smoking cessation in pregnancy: randomised controlled trial
Abstract
Commentary
POINT: Does the Risk of Electronic Cigarettes Exceed Potential Benefits? Yes
Abstract
Commentary
Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence
Abstract
Commentary
3.3 Lung Cancer Screening
An Official American Thoracic Society/American College of Chest Physicians Policy Statement: Implementation of Low-Dose Computed Tomography Lung Cancer Screening Programs in Clinical Practice
Abstract
Commentary
Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography
Abstract
Commentary
Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
Abstract
Commentary
Racial Differences in Outcomes within the National Lung Screening Trial: Implications for Widespread Implementation
Abstract
Commentary
3.4 Diagnostic Evaluation
Recent Trends in the Identification of Incidental Pulmonary Nodules
Abstract
Commentary
A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer
Abstract
Commentary
Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study
Abstract
Commentary
Technical Aspects of Endobronchial Ultrasound Guided Transbronchial Needle Aspiration: CHEST Guideline and Expert Panel Report
Abstract
Commentary
Close Surveillance with Long-Term Follow-up of Subjects with Preinvasive Endobronchial Lesions
Abstract
Commentary
PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer
Abstract
Commentary
3.5 Lung Cancer Treatment
Lobectomy, Sublobar Resection, and Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancers in the Elderly
Abstract
Commentary
Stereotactic Body Radiation Therapy Versus No Treatment for Early Stage Non-Small Cell Lung Cancer in Medically Inoperable Elderly Patients: A National Cancer Data Base Analysis
Abstract
Commentary
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
Abstract
Commentary
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Abstract
Commentary
AZD9291 in EGFR Inhibitor-Resistant Non-Small-Cell Lung Cancer
Abstract
Commentary
Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer
Abstract
Commentary
3.6 Molecular Approach to Lung Cancer
Cancer Immunology: Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Abstract
Commentary
4. Pleural, Interstitial Lung, and Pulmonary Vascular Disease
4.1 Interstitial Lung Disease
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
Abstract
Commentary
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
Abstract
Commentary
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Abstract
Commentary
Health Care Utilization and Costs of Idiopathic Pulmonary Fibrosis in U.S. Medicare Beneficiaries Aged 65 Years and Older
Abstract
Commentary
Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations
Abstract
Commentary
A Pneumocyte-Macrophage Paracrine Lipid Axis Drives the Lung toward Fibrosis
Abstract
Commentary
Telomere Length in Interstitial Lung Diseases
Abstract
Commentary
Recombinant Human Thrombomodulin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Abstract
Commentary
4.2 Pleural Disease
The Use of Indwelling Tunneled Pleural Catheters for Recurrent Pleural Effusions in Patients With Hematologic Malignancies: A Multicenter Study
Abstract
Commentary
Intrapleural Fibrinolysis for the Treatment of Indwelling Pleural Catheter-Related Symptomatic Loculations: A Multicenter Observational Study
Abstract
Commentary
Pleural irrigation trial (PIT): a randomised controlled trial of pleural irrigation with normal saline versus standard care in patients with pleural infection
Abstract
Commentary
The utility of ultrasound-guided thoracentesis and pleural biopsy in undiagnosed pleural exudates
Abstract
Commentary
Mortality among patients with pleural effusion undergoing thoracentesis
Abstract
Commentary
4.3 Pulmonary Vascular Disease
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
Abstract
Commentary
Five-Year Outcomes of Patients Enrolled in the REVEAL Registry
Abstract
Commentary
Incidence of Pulmonary Hypertension in Patients With Systemic Sclerosis and No Pulmonary Symptoms: Is Annual Echocardiographic Screening Necessary?
Abstract
Commentary
Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Abstract
Commentary
Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial
Abstract
Commentary
Identification of Low-Risk Patients with Acute Symptomatic Pulmonary Embolism for Outpatient Therapy
Abstract
Commentary
Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care
Abstract
Commentary
National Trends in Pulmonary Embolism Hospitalization Rates and Outcomes for Adults Aged =65 Years in the United States (1999 to 2010)
Abstract
Commentary
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Abstract
Commentary
5. Community-Acquired Pneumonia
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis
Abstract
Commentary
Ten-Year Mortality after Community-acquired Pneumonia: A Prospective Cohort
Abstract
Commentary
Association Between Hospitalization for Pneumonia and Subsequent Risk of Cardiovascular Disease
Abstract
Commentary
Association of Intensive Care Unit Admission With Mortality Among Older Patients With Pneumonia
Abstract
Commentary
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
Abstract
Commentary
Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012
Abstract
Commentary
Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against Invasive Disease and Hospital-Treated Pneumonia Among People Aged =65 Years: A Retrospective Case-Control Study
Abstract
Commentary
Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia
Abstract
Commentary
Pneumonia Pathogen Characterization Is an Independent Determinant of Hospital Readmission
Abstract
Commentary
Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination
Abstract
Commentary
The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia
Abstract
Commentary
Assessment of Risks of Pulmonary Infection During 12 Months Following Immunosuppressive Treatment for Active Connective Tissue Diseases: A Large-scale Prospective Cohort Study
Abstract
Commentary
Risk of Pneumonia in New Users of Cholinesterase Inhibitors for Dementia
Abstract
Commentary
First Human Challenge Testing of a Pneumococcal Vaccine: Double-Blind Randomized Controlled Trial
Abstract
Commentary
6. Lung Transplantation
Lung Transplantation With Lungs From Older Donors: Recipient and Surgical Factors Affect Outcomes
Abstract
Commentary
Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation
Abstract
Commentary
Association Between Prolonged Graft Ischemia and Primary Graft Failure or Survival Following Lung Transplantation
Abstract
Commentary
Lung transplantation from donation after cardiocirculatory death: a systematic review and meta-analysis
Abstract
Commentary
Is There an Age Limit to Lung Transplantation?
Abstract
Commentary
Body Composition and Mortality after Adult Lung Transplantation in the United States
Abstract
Commentary
Determining eligibility for lung transplantation: A nationwide assessment of the cutoff glomerular filtration rate
Abstract
Commentary
Influence of age on survival in adult patients on extracorporeal membrane oxygenation before lung transplantation
Abstract
Commentary
Clinical and demographic factors associated with post-lung transplantation survival in individuals with cystic fibrosis
Abstract
Commentary
Clinical outcomes of lung transplant recipients with telomerase mutations
Abstract
Commentary
The Natural History of Lung Function after Lung Transplantation for a1-Antitrypsin Deficiency
Abstract
Commentary
Longitudinal Forced Vital Capacity Monitoring as a Prognostic Adjunct after Lung Transplantation
Abstract
Commentary
Continued Utility of Single-Lung Transplantation in Select Populations: Chronic Obstructive Pulmonary Disease
Abstract
Commentary
7. Sleep Disorders
7.1 Central Sleep Apnea And Heart Failure
Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure
Abstract
Commentary
7.2 Sleep-Disordered Breathing Outcomes
Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans
Abstract
Commentary
Obstructive sleep apnoea in the elderly: role of continuous positive airway pressure treatment
Abstract
Commentary
Perioperative Assessment and Management for Sleep Apnea in the Ambulatory Surgical Patient
Abstract
Commentary
7.3 Cpap Treatment And Benefits
Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology
Abstract
Commentary
A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial
Abstract
Commentary
7.4 Non-Cpap Treatment of Sleep-Disordered Breathing
Surgical Management of OSA in Adults
Abstract
Commentary
7.5 Pediatric Sleep-Disordered Breathing
Sleep Disordered Breathing and Academic Performance: A Meta-analysis
Abstract
Commentary
7.6 Epidemiology of Sleep-Disordered Breathing
Racial/Ethnic Differences in Sleep Disturbances: The Multi-Ethnic Study of Atherosclerosis (MESA)
Abstract
Commentary
7.7 Non-Pulmonary Sleep
Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis
Abstract
Commentary
8. Critical Care Medicine
8.1 Acute Respiratory Disorder Syndrome
Determination of Lung Volume and Hemodynamic Changes During High-Frequency Ventilation Recruitment in Preterm Neonates with Respiratory Distress Syndrome
Abstract
Commentary
Soluble Receptor for Advanced Glycation End-Products Predicts Impaired Alveolar Fluid Clearance in Acute Respiratory Distress Syndrome
Abstract
Commentary
Influenza-Induced Priming and Leak of Human Lung Microvascular Endothelium upon Exposure to Staphylococcus aureus
Abstract
Commentary
Acute respiratory distress syndrome in patients with and without diffuse alveolar damage: an autopsy study
Abstract
Commentary
Estimating Dead-Space Fraction for Secondary Analyses of Acute Respiratory Distress Syndrome Clinical Trials
Abstract
Commentary
8.2 Acute Respiratory Failure
CPAP and High-Flow Nasal Cannula Oxygen in Bronchiolitis
Abstract
Commentary
Positive end-expiratory pressure titration at bedside using electrical impedance tomography in post-operative cardiac surgery patients
Abstract
Commentary
Driving Pressure and Survival in the Acute Respiratory Distress Syndrome
Abstract
Commentary
Extravascular Lung Water and Pulmonary Vascular Permeability Index as Markers Predictive of Postoperative Acute Respiratory Distress Syndrome: A Prospective Cohort Investigation
Abstract
Commentary
Veno-venous extracorporeal CO2 removal improves pulmonary hemodynamics in a porcine ARDS model
Abstract
Commentary
Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial
Abstract
Commentary
8.3 Cardiopulmonary Interactions
Hemodynamic instability in patients undergoing pulmonary embolectomy: institutional experience
Abstract
Commentary
Extracorporeal cardiopulmonary resuscitation in bedside echocardiography-diagnosed massive pulmonary embolism
Abstract
Commentary
Successful use of ECMO as a bridge to surgical embolectomy in Life-Threatening Pulmonary Embolism
Abstract
Commentary
First description of successful weaning from ECMO in a patient with Eisenmenger syndrome after repair of pulmonary artery dissection
Abstract
Commentary
Hemodynamic Deterioration During Extracorporeal Membrane Oxygenation Weaning in a Patient With a Total Artificial Heart
Abstract
Commentary
8.4 Miscellaneous
Safety and efficacy of ultrasound-accelerated catheter-directed lytic therapy in acute pulmonary embolism with and without hemodynamic instability
Abstract
Commentary
A new device for the prevention of pulmonary embolism in critically ill patients: Results of the European Angel Catheter Registry
Abstract
Commentary
Failure of Anticoagulant Thromboprophylaxis: Risk Factors in Medical-Surgical Critically Ill Patients
Abstract
Commentary
Pulmonary embolism in the setting of HELLP syndrome
Abstract
Commentary
Respiratory Syncytial Virus Genomic Load and Disease Severity Among Children Hospitalized With Bronchiolitis: Multicenter Cohort Studies in the United States and Finland
Abstract
Commentary
TRPV4 Is Required for Hypoxic Pulmonary Vasoconstriction
Abstract
Commentary
8.5 Pulmonary Hypertension In the ICU
Mechanical Support for the Failing Right Ventricle in Patients With Precapillary Pulmonary Hypertension
Abstract
Commentary
Scleroderma and pulmonary hypertension complicating two pregnancies: use of neuraxial anesthesia, general anesthesia, epoprostenol and a multidisciplinary approach for cesarean delivery
Abstract
Commentary
8.6 Imaging and monitoring in the ICU
Acute Lung Injury After Bilateral Lung Transplantation Due to Contralateral Pulmonary Arterial Anastomotic Obstruction
Abstract
Commentary

Systemvoraussetzungen

Als PDF speichern Als Link merken